Farah Ali
No ORCID on file
· 1 paper in corpus
nonrandomized-trial
2020
BACKGROUND AND OBJECTIVE: Elagolix is an oral, non-peptide, gonadotropin-releasing hormone receptor antagonist. It is approved for the treatment of moderate-to-severe pain associated with endometriosis and is being investigated for the trea…